The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Compounded drugs are custom-made ... receptor agonist. A key difference between compounded semaglutide and Ozempic is the lack of FDA approval for compounded semaglutide. Some compounded ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

GLP-1 agonists are only available through ... which is available over the counter, FDA-approved weight loss drugs require a prescription from a licensed healthcare professional, such as a primary ...

Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine ...

New Delhi: Taking tirzepatide drug once ... GLP-1 receptors to signal fullness or satiety. Tirzepatide was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...